Therapeutic Class Selection

Therapeutic Class Selection is the systematic process of identifying and prioritizing a category of pharmacological agents sharing a common mechanism of action or clinical indication based on patient-specific factors, efficacy, safety, and evidence-based guidelines to guide optimal medication therapy.

29

Publications

1.3K

Citations

103

Authors

77

Institutions

Publications per year

2017–2026

4

Authors

103

  1. FM
    Frank M. DiCapua

    Pfizer (United States), United States

    1 publications · 108 citations

    1

    h-index

  2. MG
    Michael G. Fehlings

    University of Toronto, Canada

    1 publications · 20 citations

    1

    h-index

  3. LN
    Loris Nanni

    University of Bologna, Italy

    1 publications · 29 citations

    1

    h-index

  4. AG
    Adeline Gallini

    Inserm, France

    1 publications · 14 citations

    1

    h-index

  5. GV
    Gert Van Assche

    KU Leuven, Belgium

    1 publications · 71 citations

    1

    h-index

1–5 of 103

Venues

  1. New England Journal of Medicine

    NEJM · 2 publications · 42 citations

    2

    h-index

  2. American Journal of Health-System Pharmacy

    AJHP · 2 publications · 111 citations

    2

    h-index

  3. Drug Discoveries & Therapeutics

    DD&T · 1 publications · 12 citations

    1

    h-index

  4. Journal of Microbiology Immunology and Infection

    JMII · 1 publications · 10 citations

    1

    h-index

  5. Journal of Medicinal Chemistry

    1 publications · 108 citations

    1

    h-index

1–5